Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy

Arthritis Care and Research - United States
doi 10.1002/acr.22470
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

SAT0200 Biologic Therapy Retention in Rheumatoid Arthritis (RA) Patients (PTS) According to the Moscow Arthritis Registry (MAR)

2017English

AB0432 Biologic Dmards Treatment Retention in Patients With Rheumatoid Arthritis According to the Moscow Arthritis Registry (MERA)

2018English

FRI0754-HPR Impact of Corticosteroid Utilization on Biologic Disease-Modifying Antirheumatic Drug Initiation Among Patients With Rheumatoid Arthritis

2017English

Should Disease-Modifying Therapy Be Stopped in Patients With Rheumatoid Arthritis Before Endoprosthetic Joint Replacement?

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2011English

Selected Problems of Biologic Therapy in Rheumatoid Arthritis Patients – Pregnancy During Therapy.

Reumatologia
RheumatologyAllergyImmunology
2013English

Points From Letters: Rheumatoid Arthritis and Herpes Zoster

BMJ
1949English

Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs

Reumatologia
RheumatologyAllergyImmunology
2014English

Comparative Risk of Diabetes Mellitus in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Drugs: A Cohort Study

ACR Open Rheumatology
2020English

Leflunomide in Disease Modifying Treatment of Rheumatoid Arthritis in Elderly Patients

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy